Author of the publication

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

, , , , , , , , , , and . Leukemia, 35 (1): 201--214 (2021)
DOI: 10.1038/s41375-020-0840-y

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Bioinformatics Strategies for Identifying Regions of Epigenetic Deregulation Associated with Aberrant Transcript Splicing and RNA-editing., , , , , , , , , and 13 other author(s). BIOINFORMATICS, page 163-170. SciTePress, (2015)Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma, , , , , , , , , and 10 other author(s). Leukemia, (Jan 31, 2023)RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS, , , , , , , , , and 7 other author(s). Haematologica, (October 2019)Hierarchy of mono- and biallelic TP53 alterations in multiple myeloma cell fitness, , , , , , , , , and 10 other author(s). Blood, 134 (10): 836--840 (September 2019)Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and Germany., , , , , , , , , and 8 other author(s). Frontiers Artif. Intell., (2021)Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab, , , , , , , , , and 1 other author(s). Leukemia, 35 (1): 201--214 (2021)Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma, , , , , , , , , and 17 other author(s). Nature Medicine, 27 (4): 616--619 (Feb 22, 2021)